DETEC® Esterase for Screening Wound Infection at Point of Care

Status unconfirmed

Conditions studied: Diabetic Foot Ulcer, Venous Leg Ulcer, Pressure Ulcer

In brief

This non-interventional, single-blinded, prospective, observational study assesses the planar distribution of leukocyte esterase in wounds by placing wound exudates soaked wound dressings in the DETEC® Esterase device during routine wound care. The output of the device is correlated with clinical determination of infection to assess the device efficacy in identifying presumptive infections.

Key facts

Study ID
NCT04614870
Run by
Progenitec Inc.
People needed
200
Starts
2022-05-01
Expected to finish
2024-12-31
Last updated by the study team
2023-11-18

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.